|
| ID |
DDInter636 |
| Drug Type |
small molecule |
| Molecular Formula |
C23H27Clo7 |
| Molecular Weight |
450.915
|
| Description |
Empagliflozin is an SGLT2 inhibitor used to manage type 2 diabetes mellitus.
|
| ATC Classification |
A10BD19
A10BD20
A10BK03
|
| IUPAC Name |
(2S,3R,4R,5S,6R)-2-[4-Chloro-3-({4-[(3S)-Oxolan-3-Yloxy]Phenyl}Methyl)Phenyl]-6-(Hydroxymethyl)Oxane-3,4,5-Triol |
| InChI |
Inchi=1S/C23H27Clo7/C24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/H1-6,10,17,19-23,25-28H,7-9,11-12H2/T17-,19+,20+,21-,22+,23-/M0/S1 |
| InChI Key |
OBWASQILIWPZMG-QZMOQZSNSA-N |
| Canonical SMILES |
OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C1=CC=C(Cl)C(CC2=CC=C(O[C@H]3CCOC3)C=C2)=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|